Skip to main content
SpringerLink
Log in

A Correlation Between Intracellular Zinc Content and Osteosarcoma

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Zinc is a trace element in human body involved in many biological processes. It is critical for cell growth and acts as a cofactor for the structure and function of a wide range of cellular proteins such as enzymes. Mounting evidence has shown the involvement of intracellular zinc in the bone-related biological processes such as bone growth, homeostasis, and regeneration; however, the molecular mechanism(s) whereby zinc impels tumorigenesis in bone remains largely unexplored. In this article, selective outline related to the content of intracellular zinc in osteosarcoma cells was provided, and its correlation with signaling molecules that are activated and consequently guide the cells toward tumorigenesis or osteogenesis was discussed. Based on preclinical and clinical evidence, dysregulation of zinc homeostasis, both at intracellular and tissue level, has the main role in the pathogenesis of osteosarcoma. Based on the intracellular zinc content, this element could have a direct role in the dynamics of bone cell transformation and tumor development and play an indirect role in the modulation of the inflammatory and pro/antitumorigenic responses in immune cells. In this context, zinc transporters and the proteins containing zinc domain are regulated by the availability of zinc, playing a crucial role in bone cell transformation and differentiation. According to recent studies, it seems that intracellular zinc levels could be considered as an early prognosis marker. Besides, identification and targeting of zinc-dependent signaling molecules could tilt the balance of life and death toward the latter in chemoresistant malignant cells and may pave a way for designing of the novel osteosarcoma treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. He H, Ni J, Huang J (2014) Molecular mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett 7(5):1352–1362

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Miller CW, Aslo A, Won A, Tan M, Lampkin B, Koefflar HP (1996) Alterations of thep53, Rb andMDM2 genes in osteosarcoms. J Cancer Res Clin Oncol 122(9):559–565

    CAS  PubMed  Google Scholar 

  3. Rejniak KA, Lloyd MC, Reed DR, Bui MM (2015) Diagnostic assessment of osteosarcoma chemoresistance based on Virtual Clinical Trials. Med Hypotheses 85(3):348–354

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Krężel A, Maret W (2006) Zinc-buffering capacity of a eukaryotic cell at physiological pZn. J Biol Inorg Chem 11(8):1049–1062

    PubMed  Google Scholar 

  5. Maret W (2015) Analyzing free zinc (ii) ion concentrations in cell biology with fluorescent chelating molecules. Metallomics 7(2):202–211

    CAS  PubMed  Google Scholar 

  6. Vallee BL, Falchuk KH (1993) The biochemical basis of zinc physiology. Physiol Rev 73(1):79–118

    CAS  PubMed  Google Scholar 

  7. Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, Sato E, Kurosaki T, Yamashita S, Tokunaga M, Nishida K, Hirano T (2007) Zinc is a novel intracellular second messenger. J Cell Biol 177(4):637–645

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T (2011) Zinc homeostasis and signaling in health and diseases. J Biol Inorg Chem 16(7):1123–1134

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Murakami M, Hirano T (2008) Intracellular zinc homeostasis and zinc signaling. Cancer Sci 99(8):1515–1522

    CAS  PubMed  Google Scholar 

  10. Kitamura H, Morikawa H, Kamon H, Iguchi M, Hojyo S, Fukada T, Yamashita S, Kaisho T, Akira S, Murakami M, Hirano T (2006) Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol 7(9):971–977

    CAS  PubMed  Google Scholar 

  11. Yamashita S, Miyagi C, Fukada T, Kagara N, Che Y-S, Hirano T (2004) Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature 429(6989):298–302

    CAS  PubMed  Google Scholar 

  12. Zhang N, Duncan FE, Que EL, O’Halloran TV, Woodruff TK (2016) The fertilization-induced zinc spark is a novel biomarker of mouse embryo quality and early development. Sci Rep 6:22772

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Yu M, Lee W-W, Tomar D, Pryshchep S, Czesnikiewicz-Guzik M, Lamar DL, Li G, Singh K, Tian L, Weyand CM, Goronzy JJ (2011) Regulation of T cell receptor signaling by activation-induced zinc influx. J Exp Med 208(4):775–785

    CAS  PubMed  PubMed Central  Google Scholar 

  14. O'Connor JP, Kanjilal D, Teitelbaum M, Lin SS, Cottrell JA (2020) Zinc as a therapeutic agent in bone regeneration. Materials (Basel) 13(10):2211

    CAS  Google Scholar 

  15. Amin N, Clark CCT, Taghizadeh M, Djafarnejad S (2020) Zinc supplements and bone health: The role of the RANKL-RANK axis as a therapeutic target. J Trace Elem Med Biol 57:126417

    CAS  PubMed  Google Scholar 

  16. Chen D, Waite LC, Pierce WM (1998) In vitro bone resorption is dependent on physiological concentrations of zinc. Biol Trace Elem Res 61(1):9–18

    CAS  PubMed  Google Scholar 

  17. Sun J-Y, Wang J-F, Zi N-T, Jing M-Y, Weng X-Y (2011) Effects of zinc supplementation and deficiency on bone metabolism and related gene expression in rat. Biol Trace Elem Res 143(1):394–402

    CAS  PubMed  Google Scholar 

  18. Yamaguchi M (2010) Role of nutritional zinc in the prevention of osteoporosis. Mol Cell Bioch 338(1-2):241–254

    CAS  Google Scholar 

  19. Park JH, Grandjean CJ, Antonson DL, Vanderhoof JA (1986) Effects of isolated zinc deficiency on the composition of skeletal muscle, liver and bone during growth in rats. J Nutr 116(4):610–617

    CAS  PubMed  Google Scholar 

  20. Windisch W, Wher U, Rambeck W, Erben R (2002) Effect of Zn deficiency and subsequent Zn repletion on bone mineral composition and markers of bone tissue metabolism in 65Zn-labelled, young-adult rats. J Anim Physiol Anim Nutr 86(7-8):214–221

    CAS  Google Scholar 

  21. Gurban CV, Mederle O (2011) The OPG/RANKL system and zinc ions are promoters of bone remodeling by osteoblast proliferation in postmenopausal osteoporosis. Romanian journal of morphology and embryology. Rev Roum Morphol Embryol 52(3 Suppl):1113–1119

    Google Scholar 

  22. Park KH, Choi Y, Yoon DS, Lee KM, Kim D, Lee JW (2018) Zinc promotes osteoblast differentiation in human mesenchymal stem cells via activation of the cAMP-PKA-CREB signaling pathway. Stem Cells Dev 27(16):1125–1135

    CAS  PubMed  Google Scholar 

  23. Meshkini A, Oveisi H (2017) Methotrexate-F127 conjugated mesoporous zinc hydroxyapatite as an efficient drug delivery system for overcoming chemotherapy resistance in osteosarcoma cells. Colloids Surf B 158:319–330

    CAS  Google Scholar 

  24. Atkins GJ, Findlay DM, Anderson PH, Morris HA (2011) Chapter 23 - target genes: bone proteins. In: Feldman D, Pike JW, Adams JS (eds) Vitamin D, 3rd edn. Academic Press, San Diego, pp 411–424

    Google Scholar 

  25. Chen D, Waite LC, Pierce WM (1999) In vitro effects of zinc on markers of bone formation. Biol Trace Elem Res 68(3):225–234

    CAS  PubMed  Google Scholar 

  26. Coleman JE (1992) Structure and mechanism of alkaline phosphatase. Ann Rev Biophysics Biomol Struct 21:441–483

    CAS  Google Scholar 

  27. Hove E, Elvehjem C, Hart E (1940) The effect of zinc on alkaline phosphatases. J Biol Chem 134:425

    CAS  Google Scholar 

  28. Ferreira ECS, Bortolin RH, Freire-Neto FP, Souza KSC, Bezerra JF, Ururahy MAG, Ramos AMO, Himelfarb ST, Abreu BJ, Didone TVN, Pedrosa LFC, Medeiros AC, Doi SQ, Brandão-Neto J, Hirata RDC, Rezende LA, Almeida MG, Hirata MH, Rezende AA (2017) Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats. Nutr Res 40:48–56

    CAS  PubMed  Google Scholar 

  29. Liu W, Zhang X (2015) Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review). Mol Med Rep 11(5):3212–3218

    CAS  PubMed  Google Scholar 

  30. Wu X, Li F, Dang L, Liang C, Lu A, Zhang G (2020) RANKL/RANK system-based mechanism for breast cancer bone metastasis and related therapeutic strategies. Front Cell Dev Biol 8:76

    PubMed  PubMed Central  Google Scholar 

  31. Tobeiha M, Moghadasian MH, Amin N, Jafarnejad S (2020) RANKL/RANK/OPG pathway: a mechanism involved in exercise-induced bone remodeling. BioMed Res Int 2020:6910312

    PubMed  PubMed Central  Google Scholar 

  32. Ono T, Hayashi M, Sasaki F, Nakashima T (2020) RANKL biology: bone metabolism, the immune system, and beyond. Inflammation Regener 40(1):2

    CAS  Google Scholar 

  33. Ardeshirpour L, Dumitru C, Dann P, Sterpka J, VanHouten J, Kim W, Kostenuik P, Wysolmerski J (2015) OPG treatment prevents bone loss during lactation but does not affect milk production or maternal calcium metabolism. Endocrinology 156(8):2762–2773

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12(9):1260–1268

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Hie M, Tsukamoto I (2011) Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone. Eur J Pharmacol 668(1):140–146

    CAS  PubMed  Google Scholar 

  36. Fong L, Tan K, Tran C, Cool J, Scherer MA, Elovaris R, Coyle P, Foster BK, Rofe AM, Xian CJ (2009) Interaction of dietary zinc and intracellular binding protein metallothionein in postnatal bone growth. Bone 44(6):1151–1162

    CAS  PubMed  Google Scholar 

  37. Fushimi H, Inoue T, Yamada Y, Horie H, Kameyama M, Inoue K, Minami T, Okazaki Y (1993) Zinc deficiency exaggerates diabetic osteoporosis. Diabetes Res Clin Pract 20(3):191–196

    CAS  PubMed  Google Scholar 

  38. Qi S, He J, Zheng H, Chen C, Jiang H, Lan S (2020) Zinc supplementation increased bone mineral density, improves bone histomorphology, and prevents bone loss in diabetic rat. Biol Trace Elem Res 194(2):493–501

    CAS  PubMed  Google Scholar 

  39. Bortolin RH, da Graça Azevedo Abreu BJ, Abbott Galvão Ururahy M, Costa de Souza KS, Bezerra JF, Loureiro MB et al (2015) Protection against T1DM-induced bone loss by zinc supplementation: biomechanical, histomorphometric, and molecular analyses in STZ-induced diabetic rats. PloS One 10(5):e0125349-e

    Google Scholar 

  40. Iitsuka N, Hie M, Tsukamoto I (2013) Zinc supplementation inhibits the increase in osteoclastogenesis and decrease in osteoblastogenesis in streptozotocin-induced diabetic rats. Eur J Pharmacol 714(1-3):41–47

    CAS  PubMed  Google Scholar 

  41. Zheng H, Qi S, Chen C (2018) Salidroside improves bone histomorphology and prevents bone loss in ovariectomized diabetic rats by upregulating the OPG/RANKL ratio. Molecules 23(9):2398

    PubMed Central  Google Scholar 

  42. Nimmanon T, Taylor KM (2019) Post-translational mechanisms of zinc signalling in cancer. In: Fukada T, Kambe T (eds) Zinc Signaling. Springer Singapore, Singapore, pp 319–345

    Google Scholar 

  43. Gumulec J, Masarik M, Krizkova S, Adam V, Hubalek J, Hrabeta J, Eckschlager T, Stiborova M, Kizek R (2011) Insight to physiology and pathology of zinc (II) ions and their actions in breast and prostate carcinoma. Curr Med Chem 18(33):5041–5051

    CAS  PubMed  Google Scholar 

  44. Huang T, Yan G, Guan M (2020) Zinc homeostasis in bone: zinc transporters and bone diseases. Int J Mol Sci 21(4):1236

    CAS  PubMed Central  Google Scholar 

  45. Alam S, Kelleher SLJN (2012) Cellular mechanisms of zinc dysregulation: a perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer. Nutrients 4(8):875–903

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Skrajnowska D, Bobrowska-Korczak B (2019) Role of zinc in immune system and anti-cancer defense mechanisms. Nutrients 11(10):2273

    CAS  PubMed Central  Google Scholar 

  47. Mulay IL, Roy R, Knox BE, Suhr NH, Delaney WE (1971) Trace-metal analysis of cancerous and non-cancerous human tissues2. J Natl Cancer Inst 47(1):1–13

    CAS  PubMed  Google Scholar 

  48. Bafaro E, Liu Y, Xu Y, Dempski RE (2017) The emerging role of zinc transporters in cellular homeostasis and cancer. Signal Transduct Target Ther 2:17029

    PubMed  PubMed Central  Google Scholar 

  49. Costello LC, Franklin RB (2006) The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 5:17

    PubMed  PubMed Central  Google Scholar 

  50. To PK, Do MH, Cho J-H, Jung C (2020) Growth modulatory role of zinc in prostate cancer and application to cancer therapeutics. Int J Mol Sci 21(8):2991

    PubMed Central  Google Scholar 

  51. Chen QG, Zhang Z, Yang Q, Shan GY, Yu XY, Kong CZ (2012) The role of zinc transporter ZIP4 in prostate carcinoma. Urol Oncol 30(6):906–911

    CAS  PubMed  Google Scholar 

  52. Han CT, Schoene NW, Lei KY (2009) Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells. Am J Physiology Cell Physiol 297(5):C1188–C1199

    CAS  Google Scholar 

  53. Gao K, Zhang Y, Niu J, Nie Z, Liu Q, Lv C (2020) Zinc promotes cell apoptosis via activating the Wnt-3a/β-catenin signaling pathway in osteosarcoma. J Orthopaedic Surg Res 15(1):57

    Google Scholar 

  54. Ziliotto S, Ogle O, Taylor KM (2018) Targeting zinc(II) signalling to prevent cancer. Met Ions life Sci 18:507–530

  55. Behnamsani A, Meshkini A (2019) Synthesis and engineering of mesoporous ZnO@HAP heterostructure as a pH-sensitive nano-photosensitizer for chemo-photodynamic therapy of malignant tumor cells. J Drug Delivery Sci Technol 53:101200

    CAS  Google Scholar 

  56. Cerovic A, Miletic I, Sobajic S, Blagojevic D, Radusinovic M, El-Sohemy A (2007) Effects of zinc on the mineralization of bone nodules from human osteoblast-like cells. Biol Trace Elem Res 116(1):61–71

    CAS  PubMed  Google Scholar 

  57. Gutiérrez MF, Alegría-Acevedo LF, Méndez-Bauer L, Bermudez J, Dávila-Sánchez A, Buvinic S, Hernández-Moya N, Reis A, Loguercio AD, Farago PV, Martin J, Fernández E (2019) Biological, mechanical and adhesive properties of universal adhesives containing zinc and copper nanoparticles. J Dent 82:45–55

    PubMed  Google Scholar 

  58. Begam H, Kundu B, Chanda A, Nandi SK (2017) MG63 osteoblast cell response on Zn doped hydroxyapatite (HAp) with various surface features. Ceram Int 43(4):3752–3760

    CAS  Google Scholar 

  59. Tsukahara T, Nabeta Y, Kawaguchi S, Ikeda H, Sato Y, Shimozawa K, Ida K, Asanuma H, Hirohashi Y, Torigoe T, Hiraga H, Nagoya S, Wada T, Yamashita T, Sato N (2004) Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor. Cancer Res 64(15):5442–5448

    CAS  PubMed  Google Scholar 

  60. Endo-Munoz L, Cumming A, Sommerville S, Dickinson I, Saunders NA (2010) Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone. Br J Cancer 103(1):73–81

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Habel N, Hamidouche Z, Girault I, Patiño-García A, Lecanda F, Marie PJ et al (2013) Zinc chelation: a metallothionein 2A’s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance. Cell Death Dis 4(10):e874-e

    Google Scholar 

  62. Krizkova S, Masarik M, Majzlik P, Kukacka J, Kruseova J, Adam V, Prusa R, Eckschlager T, Stiborova M, Kizek R (2010) Serum metallothionein in newly diagnosed patients with childhood solid tumours. Acta biochim Pol 57(4):561–566

    CAS  PubMed  Google Scholar 

  63. Si M, Lang J (2018) The roles of metallothioneins in carcinogenesis. J Hematol Oncol 11(1):107

    PubMed  PubMed Central  Google Scholar 

  64. Eckschlager T, Adam V, Hrabeta J, Figova K, Kizek R (2009) Metallothioneins and cancer. Curr Protein Pept Sci 10(4):360–375

    CAS  PubMed  Google Scholar 

  65. Abdel-Mageed AB, Agrawal KC (1998) Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response. Cancer Res 58(11):2335–2338

    CAS  PubMed  Google Scholar 

  66. Ostrakhovitch EA, Olsson P-E, Jiang S, Cherian MG (2006) Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett 580(5):1235–1238

    CAS  PubMed  Google Scholar 

  67. Guo W, Zhao YP, Jiang YG, Wang RW, Hong L, Fan DM (2008) ZNRD1 might mediate UV irradiation related DNA damage and repair in human esophageal cancer cells by regulation of ERCC1. Dis Esophagus 21(8):730–736

    CAS  PubMed  Google Scholar 

  68. Hong L, Chen Z, Zhang X, Xia L, Han Z, Lu Y, Jin H, Song J, Qiao T, Fan D (2006) Zinc ribbon domain containing 1 protein: modulator of multidrug resistance, tumorigenesis and cell cycle. Exp Oncol 28(4):258–262

    CAS  PubMed  Google Scholar 

  69. Xie B, Li Y, Zhao R, Xu Y, Wu Y, Wang J et al (2018) Identification of key genes and miRNAs in osteosarcoma patients with chemoresistance by bioinformatics analysis. BioMed Res Int 2018:4761064

    PubMed  PubMed Central  Google Scholar 

  70. Hong L, Qiao T, Han Y, Han S, Zhang X, Lin T, Gao J, Zhao P, Chen Z, Fan D (2006) ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2. Biochemistry and cell biology. Biochim Biol Cell 84(2):199–206

    CAS  Google Scholar 

  71. Hong L, Piao Y, Han Y, Wang J, Zhang X, Du Y et al (2005) Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther 4(12):1936–1942

    CAS  PubMed  Google Scholar 

  72. Fellenberg J, Kunz P, Sähr H, Depeweg D (2010) Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells. PloS One 5(8):e12179

    PubMed  PubMed Central  Google Scholar 

  73. Kambe T, Suzuki E, Komori T (2019) Zinc transporter proteins: a review and a new view from biochemistry. In: Fukada T, Kambe T (eds) Zinc Signaling. Singapore, Springer Singapore p, pp 23–56

    Google Scholar 

  74. Pan Z, Choi S, Ouadid-Ahidouch H, Yang J-M, Beattie JH, Korichneva I (2017) Zinc transporters and dysregulated channels in cancers. Front Biosci (Landmark Ed) 22:623–643

    CAS  Google Scholar 

  75. Takatani-Nakase T (2018) Zinc Transporters and the Progression of Breast Cancers. Biol Pharm Bull 41(10):1517–1522

    CAS  PubMed  Google Scholar 

  76. Franz MC, Anderle P, Bürzle M, Suzuki Y, Freeman MR, Hediger MA, Kovacs G (2013) Zinc transporters in prostate cancer. Mol Aspects Med 34(2):735–741

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Jin J, Li Z, Liu J, Wu Y, Gao X, He Y (2015) Knockdown of zinc transporter ZIP5 (SLC39A5) expression significantly inhibits human esophageal cancer progression. Oncol Rep 34(3):1431–1439

    CAS  PubMed  Google Scholar 

  78. Tang Z, Sahu SN, Khadeer MA, Bai G, Franklin RB, Gupta A (2006) Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells. Bone 38(2):181–198

    CAS  PubMed  Google Scholar 

  79. Fu X, Li Y, Huang T, Yu Z, Ma K, Yang M et al (2018) Runx2/osterix and zinc uptake synergize to orchestrate osteogenic differentiation and citrate containing bone apatite formation. Adv Sci 5(4):1700755

    Google Scholar 

  80. Costello LC, Chellaiah MA, Zou J, Reynolds MA, Franklin RB (2015) In vitro BMP2 stimulation of osteoblast citrate production in concert with mineralized bone nodule formation. J Regener Med Tissue Eng 4:2

  81. Yu Y, Liu K, Wen Z, Liu W, Zhang L, Su J (2020) Double-edged effects and mechanisms of Zn2+ microenvironments on osteogenic activity of BMSCs: osteogenic differentiation or apoptosis. RSC Adv 10(25):14915–14927

    CAS  Google Scholar 

  82. Kim G, Elnabawi O, Shin D, E-KJFip P (2016) Transient intermittent hypoxia exposure disrupts neonatal bone strength. Front Pediatr 4:15

    PubMed  PubMed Central  Google Scholar 

  83. Sasaki S, Tsukamoto M, Saito M, Hojyo S, Fukada T, Takami M, Furuichi T (2018) Disruption of the mouse Slc39a14 gene encoding zinc transporter ZIP14 is associated with decreased bone mass, likely caused by enhanced bone resorption. FEBS Open Bio 8(4):655–663

    CAS  PubMed  PubMed Central  Google Scholar 

  84. Suzuki T, Katsumata S, Matsuzaki H, Suzuki K (2016) A short-term zinc-deficient diet decreases bone formation through down-regulated BMP2 in rat bone. Biosci Biotechnol Biochem 80(7):1433–1435

    CAS  PubMed  Google Scholar 

  85. Liu Y, Yan F, Yang WL, Lu XF, Wang WB (2013) Effects of zinc transporter on differentiation of bone marrow mesenchymal stem cells to osteoblasts. Biol Trace Elem Res 154(2):234–243

    CAS  PubMed  Google Scholar 

  86. Alluri K, Nair KPM, Kotturu SK, Ghosh S (2020) Transcriptional regulation of zinc transporters in human osteogenic sarcoma (Saos-2) cells to zinc supplementation and zinc depletion. Biol Trace Elem Re 194(2):360–367

    CAS  Google Scholar 

  87. Zhang L-C, Chen L-Y (2019) A review on biomedical titanium alloys: recent progress and prospect. Adv Eng Mater 21(4):1801215

    Google Scholar 

  88. Smolle MA, Andreou D, Tunn P-U, Leithner A (2019) Advances in tumour endoprostheses: a systematic review. EFORT Open Rev 4(7):445–459

    PubMed  PubMed Central  Google Scholar 

  89. Chouirfa H, Bouloussa H, Migonney V, Falentin-Daudré C (2019) Review of titanium surface modification techniques and coatings for antibacterial applications. Acta Biomater 83:37–54

    CAS  PubMed  Google Scholar 

  90. Eyvazi S, Vostakolaei MA, Dilmaghani A, Borumandi O, Hejazi MS, Kahroba H, Tarhriz V (2020) The oncogenic roles of bacterial infections in development of cancer. Microb Pathog 141:104019

    CAS  PubMed  Google Scholar 

  91. Agassandian M, Shurin GV (2015) Bacterial infections and cancer development. In: Shurin MR, Thanavala Y, Ismail N (eds) Infection and Cancer: Bi-Directorial Interactions. Springer International Publishing p, Cham, pp 49–74

    Google Scholar 

  92. Gao C, Li C, Wang C, Qin Y, Wang Z, Yang F, Liu H, Chang F, Wang J (2017) Advances in the induction of osteogenesis by zinc surface modification based on titanium alloy substrates for medical implants. J Alloys Compd 726:1072–1084

    CAS  Google Scholar 

  93. Fernandes MH, Alves MM, Cebotarenco M, Ribeiro IAC, Grenho L, Gomes PS, Carmezim MJ, Santos CF (2020) Citrate zinc hydroxyapatite nanorods with enhanced cytocompatibility and osteogenesis for bone regeneration. Mater Sci Eng C 115:111147

    CAS  Google Scholar 

  94. Ortiz IY, Raybolt dos Santos A, Costa AM, Mavropoulos E, Tanaka MN, Prado da Silva MH, de Souza Camargo S Jr (2016) In vitro assessment of zinc apatite coatings on titanium surfaces. Ceram Int 42(14):15502–15510

    CAS  Google Scholar 

  95. Valanezhad A, Tsuru K, Maruta M, Kawachi G, Matsuya S, Ishikawa K (2012) A new biocompatible coating layer applied on titanium substrates using a modified zinc phosphatizing method. Surf Coat Technol 206(8):2207–2212

    CAS  Google Scholar 

  96. Li G, Niu L, Lian J, Jiang Z (2004) A black phosphate coating for C1008 steel. Surf Coat Technol 176(2):215–221

    CAS  Google Scholar 

  97. Zhong Z, Qin J, Ma J (2015) Electrophoretic deposition of biomimetic zinc substituted hydroxyapatite coatings with chitosan and carbon nanotubes on titanium. Ceram Int 41(7):8878–8884

    CAS  Google Scholar 

  98. Yang M, Shuai Y, Zhang C, Chen Y, Zhu L, Mao C, OuYang H (2014) Biomimetic nucleation of hydroxyapatite crystals mediated by Antheraea pernyi silk sericin promotes osteogenic differentiation of human bone marrow derived mesenchymal stem cells. Biomacromolecules. 15:1185–1193

    CAS  PubMed  PubMed Central  Google Scholar 

  99. Yang Y, Tao B, Gong Y, Chen R, Yang W, Lin C, Chen M, Qin L, Jia Y, Cai K (2020) Functionalization of Ti substrate with pH-responsive naringin-ZnO nanoparticles for the reconstruction of large bony after osteosarcoma resection. J Biomed Mater Res Part A 108(11):2190–2205

    CAS  Google Scholar 

  100. Saxena V, Hasan A, Pandey LM (2018) Effect of Zn/ZnO integration with hydroxyapatite: a review. Mater Technol 33(2):79–92

    CAS  Google Scholar 

  101. Zhao S, Xu Y, Xu W, Weng Z, Cao F, Wan X, Cui T, Yu Y, Liao L, Wang X (2020) Tremella-like ZnO@Col-I-decorated titanium surfaces with dual-light-defined broad-spectrum antibacterial and triple osteogenic properties. ACS Appl Mater Interfaces 12(27):30044–30051

    CAS  PubMed  Google Scholar 

Download references

Funding

The authors appreciate the financial support for this investigation by the Research Council of Ferdowsi University of Mashhad.

Author information

Authors and Affiliations

  1. Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, P. O. Box 9177948974, Iran

    Azadeh Meshkini

Authors
  1. Azadeh Meshkini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Azadeh Meshkini.

Ethics declarations

Conflict of Interest

The author declares that she has no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meshkini, A. A Correlation Between Intracellular Zinc Content and Osteosarcoma. Biol Trace Elem Res 199, 3222–3231 (2021). https://doi.org/10.1007/s12011-020-02466-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-020-02466-4

Keywords

Search

Navigation